Use of MDMA and other illicit drugs by young adult males in northern Spain. A five-year study.
OBJECTIVE
To measure the prevalence of 3,4-methylenedioxymethamphetamine (MDMA) and other drug use in young males entering compulsory military service in Asturias (northern Spain) and to define trends in MDMA use in this group during the period from 1995 to 1999. We also sought to determine whether MDMA users have distinct personality features or higher levels of sensation seeking.


METHODS
3,634 conscripts [mean age (SD) = 20.19 years (2.52)] who entered military service during the period between 1995 and 1999 were evaluated using the World Health Organization (WHO) questionnaire for drug consumption, the Eysenck Personality Questionnaire-A (EPQ-A), and the Zuckerman Sensation Seeking Scale.


CONCLUSIONS
The prevalence of lifetime, previous year and previous month MDMA use among military recruits between 1995 and 1999 was 10.9, 7.8 and 4.5%, ranking fifth among illicit drugs ever used. Once individuals used MDMA for the first time, they were likely to use it again, with 71% of individuals who had ever used MDMA reporting that they had used it during the past year (ranking second only to hallucinogens), and 41% reporting having used it in the last month. Compared to recruits who had never used MDMA (but who may have used other illicit drugs), MDMA users had a more extensive drug abuse history. Recruits who had used MDMA during the year prior to study had significantly higher scores on the Neuroticism and Psychoticism Subscales of the EPQ-A, and reported higher levels of sensation seeking.
Bobes
J
J
Department of Psychiatry, Faculty of Medicine, University of Oviedo, Spain. bobes@correo.uniovi.es
Sáiz
P A
PA
González
M P
MP
Bascarán
M T
MT
Bousoño
M
M
Ricaurte
G A
GA
McCann
U D
UD
D000328:Adult; D006213:Hallucinogens; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008889:Military Personnel; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D010556:Personality Tests; D015995:Prevalence; D013030:Spain / Q000453:epidemiology; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000523:psychology
D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine